Astec LifeSciences Limited announced that the Board of Directors of the Company, based on the recommendation of the Nomination and Remuneration Committee of the Board of Directors, has appointed Mr. Burjis Godrej Director Identification Number (DIN): 08183082 as an Additional, Non-Executive, Non- Independent Director of the Company with effect from 25th July, 2022. The appointment of Mr. Burjis Godrej as an Additional, Non Executive, Non-Independent Director with effect from 25th July, 2022, is subject To Approve the Shareholders of the Company. Further, Mr. Burjis Godrej is related to the Promoters and forms a part of the Promoter Group of the Company and he is not debarred from holding the office of a Director pursuant to any Order of SEBI or any other such authority.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,181 INR | +4.36% | -1.46% | +7.79% |
03/05 | Astec Lifesciences' CFO Resigns | MT |
02/05 | Astec LifeSciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.79% | 266M | |
+17.80% | 39.03B | |
-.--% | 11.3B | |
+1.48% | 8.01B | |
+1.83% | 6.55B | |
-2.15% | 6.21B | |
+36.99% | 5.48B | |
-14.15% | 5.24B | |
-12.97% | 4.59B | |
+6.96% | 3.93B |
- Stock Market
- Equities
- ASTEC Stock
- News Astec LifeSciences Limited
- Astec Lifesciences Limited Appoints Burjis Godrej as an Additional, Non-Executive, Non- Independent Director